Biopharmaceuticals





Biopharmaceuticals
Biotech
One Hot Stock
TradersPro Alerts

Can-Fite BioPharma Ltd. (CANF) Buy Target $1.17 – Sell Target $1.65

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and liver diseases. The company’s lead drug candidate is CF101 (Piclidenoson), which is in Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis. It also develops CF102 (Namodenoson) that is in Phase II clinical […]

Read More
Biopharmaceuticals
One Hot Stock
Pharmaceuticals
TradersPro Alerts

Curis, Inc. (CRIS) Buy Signal $1.28 – Sell Signal $2.17

Curis, Inc., a biotechnology company, focuses on the development and commercialization of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CUDC-907, an oral dual inhibitor of HDAC and PI3K enzymes, which is in Phase II clinical trial for the treatment of patients with MYC-altered diffuse […]

Read More
Biopharmaceuticals
Biotech
One Hot Stock
TradersPro Alerts

Galmed Pharmaceuticals Ltd. (GLMD) Buy Target $9.04 – Sell Target $13.62

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. The company is develops Aramchol, an oral therapy, which is in ARREST study, a Phase IIb clinical study for the treatment of patients with overweight or obesity, and who are pre-diabetic or type-II-diabetic with non-alcoholic steato-hepatitis. […]

Read More
Biopharmaceuticals
One Hot Stock
TradersPro Alerts

Affimed N.V. (AFMD)

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. Its lead candidate is AFM13, a natural killer cell (NK-cell) TandAb, which is in Phase 2a clinical study of relapsed CD30-positive lymphoma and Phase 1b clinical study of anti-PD-1 antibody Keytruda (pembrolizumab) in patients with […]

Read More
Biopharmaceuticals
One Hot Stock
TradersPro Alerts

Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making […]

Read More
Biopharmaceuticals
Biotech
One Hot Stock
TradersPro Alerts

vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company’s drug candidates comprise azeliragon (TTP488), an orally administered, small molecule antagonist targeting the receptor for advanced glycation endproducts, which is in Phase III clinical trials for the treatment of Alzheimer’s disease.  Annual EPS Growth – Companies […]

Read More